The Acute Effect of Kinesio Tape on Pain, Joint Range of Motion and Dynamic Balance in Patients With Low Back Pain
December 19, 2024 updated by: Ilayda Dilan Isik, Istanbul Saglik Bilimleri University
The Acute Effect of Kinesio Tape on Pain, Joint Range of Motion and Dynamic Balance in Patients With Low Back Pain: Randomized Placebo-Controlled Trial
The aim of this study is to evaluate the acute effect of kinesio taping on pain, range of motion and dynamic balance in patients with chronic nonspecific low back pain.
48 patients were included in the study and were randomly divided into three groups by ordinal number randomization.
All patients were evaluated of pain, joint range of motion and dynamic balance before and 45 minutes after the application.
Kinesio taping with elastic therapeutic tape was applied to the core muscles of the study group, and the same muscles of the placebo group were taped with plaster tape in the same way, and no application was made to the control group.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The aim of this study is to evaluate the acute effect of kinesio taping on pain, range of motion and dynamic balance in patients with chronic nonspecific low back pain.
48 patients were included in the study and were randomly divided into three groups by ordinal number randomization.
All patients were evaluated by the same physiotherapist in terms of pain (Visual Analog Scale), joint range of motion (Gonyometric measurement) and dynamic balance (Timed Up and Go Test) before and 45 minutes after the application.
Kinesio taping with elastic therapeutic tape was applied to the transversus abdominis, rectus abdominis and iliocostal muscles of the study group, and the same muscles of the placebo group were taped with plaster tape in the same way, and no application was made to the control group.
Study Type
Interventional
Enrollment (Actual)
48
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Çankaya
-
Ankara, Çankaya, Turkey
- Animarapha Manual Therapy and Reflexology Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion criteria for the study:
- Having low back pain of at least 3 out of 10 points on the Visual Analog Scale,
- Being between the ages of 30-55,
- Having low back pain for at least 3 months,
- Having been tested with a test piece beforehand and not having an allergy to kinesio taping.
Exclusion criteria for the study:
- Having had surgery for low back pain,
- Not complying with treatment,
- Having a neurological deficit,
- Being pregnant,
- Having received any treatment for low back pain in the last month.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Kinesio Tape Group
Kinesio tape was applied to this group.
|
Kinesio tape (KT) is an elastic therapeutic tape used to treat sports injuries and various other disorders.
It was first used by Dr. Kenzo Kase in 1979 to relieve pain and promote healing in soft tissues and is a method that is constantly being updated.
The KT method is a therapeutic taping technique that relieves pain and facilitates lymphatic drainage by microscopically lifting the skin.
|
|
Placebo Comparator: Placebo Tape Group
Placebo tape was applied to this group.
|
In this application, taping was applied in the same way but with a plaster tape.
|
|
Other: Control Group
No application was made to this group.
Just rest
|
No application was made.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Analog Scale
Time Frame: 45 minute
|
It will evaluate pain.
People marked the severity of their pain on a 10 cm line.
(0: no pain, 10: maximum pain) Pain was evaluated separately as activity, rest and night.
|
45 minute
|
|
Goniometer
Time Frame: 45 minute
|
Joint range of motion was measured with a goniometer.
Spinal flexion, extension and lateral flexion were evaluated.
|
45 minute
|
|
Timed up and go test
Time Frame: 45 minute
|
Dynamic balance was assessed with timed get up and go.
The person stood up from a fixed chair, walked 3 meters and sat back down, and the time spent during this time was measured.
|
45 minute
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 15, 2021
Primary Completion (Actual)
January 5, 2022
Study Completion (Actual)
May 15, 2022
Study Registration Dates
First Submitted
December 17, 2024
First Submitted That Met QC Criteria
December 19, 2024
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
December 19, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BaskentUni
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.